Atossa Therapeutics
ATOS
ATOS
83 hedge funds and large institutions have $19.1M invested in Atossa Therapeutics in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
32% less capital invested
Capital invested by funds: $28.3M → $19.1M (-$9.17M)
38% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 29
Holders
83
Holding in Top 10
–
Calls
$123K
Puts
$58K
Top Buyers
| 1 | +$322K | |
| 2 | +$200K | |
| 3 | +$144K | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$81.4K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$28.8K |
Top Sellers
| 1 | -$450K | |
| 2 | -$404K | |
| 3 | -$197K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$163K |
| 5 |
Jane Street
New York
|
-$120K |
